Philips has received U.S. FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, introducing a redesigned pulse oximetry sensor intended to improve the accuracy and consistency of blood oxygen measurements across a broad range of patient populations. The new sensor incorporates optical enhancements designed to reduce signal interference and improve measurement reliability, supporting clinicians with more dependable data in both routine and complex care settings.
In controlled clinical desaturation studies, the reusable sensor achieved an Accuracy Root Mean Square (ARMS) value of 1.6%, significantly outperforming the 3% accuracy threshold recommended by the International Organization for Standardization (ISO) and recognized by the FDA. Philips says the improved performance stems from upgrades to the sensor's internal optical architecture, which enhances signal quality at the emitter and photodiode interface while reducing the impact of ambient light, patient movement and tissue-related variations that can affect pulse oximetry readings.
The company also emphasized the sensor's consistent performance across patients with different skin tones, an area that has drawn increasing attention from regulators and clinicians in recent years. Validation testing found that measurement accuracy differed by less than 0.5% between light- and dark-skinned participants across oxygen saturation levels ranging from 85% to 100%. Philips says these results demonstrate more consistent clinical performance across diverse patient populations and help address longstanding concerns about disparities in pulse oximetry accuracy.
The FDA clearance is supported by Philips' broader pulse oximetry validation program, which was developed in line with current FDA guidance as well as IEC and ISO standards. The company plans to introduce the reusable sensor in select global markets and intends to apply similar technological improvements across its wider pulse oximetry portfolio as part of its ongoing efforts to enhance patient monitoring and support more informed clinical decision-making.
Click here to read the original news story.
